Anatumomab mafenatox
Product Specifications
CAS Number
1370261-50-9
Bioactivity
Anatumomab mafenatox (ABR-214936), a 73 KDa recombinant protein, targets the tumor-associated antigen 5T4 commonly expressed in malignancies. It is a conjugate comprising a modified form of SEA linked to a murine Fab. The primary adverse effects of Anatumomab mafenatox include fever, hypotension, pain, nausea, and drowsiness [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CCG-1003-40 1 mL
Mannose a-O-BSA Colloidal Gold Conjugate, 1mL 40nm
Sign In for Pricing
View Details 
